Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Powershares S&P Smallcap Low Vo | XSLV | Sep 19, 2024 | 48.57 | +1.04 |
PowerShares Variable Rate Investment Grade Portfolio | VRIG | Sep 19, 2024 | 25.16 | -0.04 |
PowerUp Acquisition A | PWUP | Sep 19, 2024 | 11.59 | 0.00 |
PowerUp Acquisition Unit | PWUPU | Sep 19, 2024 | 12.75 | +7.14 |
PPG Industries | PPG | Sep 19, 2024 | 129.23 | +1.39 |
PPL | PPL | Sep 19, 2024 | 31.79 | -1.12 |
PRA Group | PRAA | Sep 19, 2024 | 23.00 | +3.23 |
Prairie Operating | PROP | Sep 19, 2024 | 9.89 | -10.17 |
Praxis Precision Medicines | PRAX | Sep 19, 2024 | 63.02 | +6.13 |
Precigen | PGEN | Sep 19, 2024 | 1.07 | +2.88 |
Precipio | PRPO | Sep 19, 2024 | 6.27 | -0.35 |
Precision BioSciences | DTIL | Sep 19, 2024 | 9.47 | -1.35 |
Precision Drilling | PDS | Sep 19, 2024 | 67.09 | +2.99 |
Precision Optics | POCI | Sep 19, 2024 | 5.85 | +0.86 |
Predictive Oncology | POAI | Sep 19, 2024 | 0.88 | +0.01 |
Preferred Bank | PFBC | Sep 19, 2024 | 83.18 | +2.51 |
Preferred Portfolio Powershares | PGX | Sep 19, 2024 | 12.50 | +0.56 |
Preformed Line Products | PLPC | Sep 19, 2024 | 122.84 | +2.88 |
Prelude Therapeutics | PRLD | Sep 19, 2024 | 2.55 | +4.51 |
Premier A | PINC | Sep 19, 2024 | 20.35 | -0.63 |
Premier Financial | PFC | Sep 19, 2024 | 25.10 | +3.51 |
Prenetics Global A | PRE | Sep 19, 2024 | 4.36 | -3.65 |
Presidio Property Trust A | SQFT | Sep 19, 2024 | 0.71 | -4.55 |
Presidio Property Trust D Pref | SQFTP | Sep 19, 2024 | 15.40 | +0.07 |
Prestige Consumer Healthcare | PBH | Sep 19, 2024 | 73.92 | +0.53 |
Prestige Wealth | PWM | Sep 19, 2024 | 0.77 | -5.68 |
PriceSmart | PSMT | Sep 19, 2024 | 91.10 | +2.29 |
Prime Medicine | PRME | Sep 19, 2024 | 3.91 | -1.76 |
Primech Holdings | PMEC | Sep 19, 2024 | 0.68 | +1.84 |
PrimeEnergy Resources | PNRG | Sep 19, 2024 | 147.40 | +5.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.